A billion people living in underdeveloped areas around the world are infected with parasitic helminthes, worms that survive by residing in and feeding on their hosts. These infestations can cause chronic intestinal…
Tag: virus
Research To Focus On Improving Delivery Of Dengue And Anthrax Vaccines
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases…
Study finds inconsistencies in methods to identify CA-BSI infection in pediatric patients
Differences have significant implications in era of mandatory public reporting and pay-for-performance A new study looking at how hospitals identify pediatric patients who develop catheter-associated bloodstream infections (CA-BSI) found significant inconsistencies in…
Researchers find new surface adaptation mechanism of biofilm-forming pathogen
Many drug-resistant infections are the result of bacterial biofilms, structured aggregates of bacteria that live on surfaces and that are extremely resistant to environmental stresses. These biofilms impact human health in many…
Researchers determine genetic structures of bacteria that cause Lyme disease
Researchers Dr. Steven E. Schutzer of UMDNJ-New Jersey Medical School and Dr. Claire M. Fraser-Liggett of the Institute for Genome Sciences, University of Maryland, and their collaborators have made a major achievement…
Researchers Determine The Genetic Blueprint Of The Lyme Disease Microbe
Researchers Dr. Steven E. Schutzer of UMDNJ-New Jersey Medical School and Dr. Claire M. Fraser-Liggett of the Institute for Genome Sciences, University of Maryland, and their collaborators have made a major achievement…
Knowledge about ecology of disease limits spread of infection
Common frog (Rana temporaria) populations across the UK are suffering dramatic population crashes due to infection from the emerging disease Ranavirus, reveals research published in the Zoological Society of London’s (ZSL) journal…
Researchers Discover ‘Walking’ Properties Of Bacteria
Talk about a walk on the wild side: University of Notre Dame researcher Joshua Shrout is co-author of a new paper that shows that bacteria are capable of “standing up” and moving…
Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine
Inviragen and PharmaJet announced the award of a five year, $15.5 million dollar contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH),…
International scientific conference to discuss combating measures for infectious disease epidemics
Swine flu … cancer … bioterrorism and the latest trends in countermeasures to combat these life-threatening diseases and infections are among the topics to be discussed at the upcoming New Cells for…
FDA files complaint for permanent injunction against Brooklyn Juice Company
At the request of the U.S. Food and Drug Administration, the U.S. Department of Justice today filed a complaint for permanent injunction against a Brooklyn juice company to prevent it from processing…
GeoVax receives US Patent for pGA series of plasmids
GeoVax Labs, Inc. (OTCQB/OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for…
Researchers unveil clues to combat enteritis in humans
The bacterium Campylobacter jejuni is a major cause of food poisoning in humans. It is normally transmitted from contaminted chicken meat, as it is frequently found in the intestines of chickens, where…
Privigen IVIg therapy effective for primary, secondary immunodeficiency patients
Privigen®, the first and only 10% liquid intravenous immunoglobulin (IVIg) therapy stabilized with proline, is effective and well tolerated in patients with several primary and secondary immunodeficiencies, according to data presented today…
Vical agrees $2.4 million contract to manufacture pDNA vaccines against HIV
Vical Incorporated (Nasdaq:VICL) today announced that the company has agreed to manufacture plasmid DNA (pDNA) vaccines against HIV under a $2.4 million contract with the IPPOX Foundation, a collaborating institution for the…